central-nervous-system-2016_posters-accepted-abstracts

4 / 42

Notes:
Page 60
CNS 2016
December 05-07, 2016
Volume 7, Issue 5(Suppl) J Neurol Neurophysiol
ISSN: 2155-9562 JNN, an open access journal
conferenceseries .com
December 05-07, 2016 Dubai, UAE
2nd International Conference on
Central Nervous System Disorders & Therapeutics
Chodounska Hana et al., J Neurol Neurophysiol 2016, 7:5(Suppl)
Current insight into the neurosteroids effect on function of NMDA receptors
Chodounska Hana and Vyklicky Ladislav
Academy of Sciences of the Czech Republic, Czech Republic
N-Methyl-D-aspartate (NMDA) receptors (NMDARs) are a major class of excitatory neurotransmitter receptors in the
central nervous system. They form glutamate-gated ion channels that are highly permeable to calcium and mediate
activity-dependent synaptic plasticity. NMDAR dysfunction is implicated in multiple brain disorders, including stroke, various
forms of neurodegeneration, chronic pain and schizophrenia. NMDARs are activated by agonists-glutamate and glycine, and
their activity is modulated by allosteric modulators including endogenous neurosteroids pregnenolone sulfate and 20-oxo-
5β-pregnan-3α-yl sulfate (PAS) and their synthetic analogues. Our recent research allowed us to identify the site of action of
PAS- the extracellular vestibule of the activated/desensitized receptor’s ion channel pore. The structure of the open channel
and recognition of molecular steps in the transition from closed to the open state provide a unique opportunity for the design
of new therapeutic, neurosteroid-based ligands to treat diseases associated with dysfunction of glutamate system. As such, a
series of pregnanolone analogues was prepared and these derivatives substituted with a carboxylic acid moiety at the end of an
aliphatic chain of varying length at C-3, have the difference in potency between tonic and phasic inhibition increased with the
length of the residue. Moreover, pregnanolone hemipimelate (PA-hPim), had no effect on phasically activated receptors while
inhibiting tonically activated receptors. In behavioral tests, PA-hPim showed neuroprotective activity without psychotomimetic
symptoms.
Biography
Chodounska Hana has completed her PhD in 1983 from Charles University in Prague. She has been working at the Institute of Organic Chemistry and Biochemistry,
Academy of Sciences of the Czech Republic in Prague from 1986. During this period, she was the PI of steroidal research group for almost 10 years. She is author
or co-author of 52 articles, 7 patents and has many contributions to scientific conferences. She has been Supervisor of undergraduate, graduate and doctoral
students and the Lecturer of the course “Chemistry of Natural Products” at the Charles University and various scientific and popularizing lectures.